Comprehensive Educational ResourceSurgical Treatment
of Lymphedema
From diagnosis and conservative management through microsurgical reconstruction and debulking procedures — an evidence-based guide for the modern clinician.
Dr. Kongkrit Chaiyasate
Board-certified plastic surgeon specializing in microsurgery and supermicrosurgery for lymphedema treatment. Dr. Chaiyasate brings advanced microsurgical expertise to provide patients with cutting-edge physiologic and ablative surgical options for lymphedema management.
Microsurgery • Supermicrosurgery • Lymphedema Surgery
Visit Main WebsiteUnderstanding Lymphedema
A chronic, progressive disease of the lymphatic system affecting millions worldwide.
Lymphedema is the accumulation of interstitial fluid and fibroadiposity in subcutaneous tissues as a result of dysfunction in the lymphatic system. Unlike generalized edema caused by increased capillary leak, lymphedema is specifically caused by poor lymphatic outflow. The disease is classified as primary (congenital, praecox, or tarda) or secondary (acquired), with secondary lymphedema being far more common in the developed world due to oncologic surgery and radiation therapy.
The pathophysiology involves initial accumulation of protein-rich lymphatic fluid, which triggers a chronic inflammatory response. Over time, this leads to progressive fibrosis and adipose tissue deposition, transforming what begins as reversible pitting edema into irreversible non-pitting swelling with significant fibrofatty changes. Worldwide, the most common cause is filariasis; in developed nations, it is most frequently iatrogenic, following axillary or inguinal lymph node dissection for cancer treatment.
Management requires a multidisciplinary approach. While conservative therapy remains the foundation, advances in microsurgery and supermicrosurgery have expanded the surgical armamentarium, offering patients physiologic restoration of lymphatic flow or effective debulking of excess tissue when conservative measures fail.
Key Epidemiology
Classification
Diagnostic Imaging
Advanced imaging modalities guide clinical decision-making and surgical planning.
Workup & Staging
Accurate diagnosis and staging are essential for determining the appropriate treatment strategy.
Clinical Evaluation
Diagnosis is primarily clinical, based on a thorough history and physical examination. The clinician must first rule out generalized edema from systemic causes (heart failure, renal failure, cirrhosis) and other limb-enlarging conditions including chronic venous insufficiency, deep venous thrombosis, and lipedema. For lymphedema, the timing of onset, travel history, family history, and any personal history of surgery or radiation are critical.
Physical examination reveals supple tissue that often "pits" when gently pressed in early stages. The classic Stemmer sign is considered positive when the examiner is unable to pinch the skin at the dorsum of the second toe or finger — a highly specific finding. Volumetric measurements through circumference measurements or water displacement testing (volume excess >200 cc is diagnostic) are used to quantify disease severity and monitor treatment response.
Imaging Modalities
Lymphoscintigraphy
The definitive diagnostic test for lymphedema. A radiotracer (⁹⁹ᵐTc-sulfur colloid) is injected into the hand or foot and tracked via gamma camera as it migrates through the lymphatic system.
Abnormal findings include delayed transit time, dermal backflow, asymmetric node uptake, and collateral channel formation.
96% sensitive, 100% specific for lymphedema.
ICG Lymphography
Indocyanine green lymphography provides real-time visualization of subdermal lymphatic channels using near-infrared fluorescence imaging.
Essential for preoperative planning of lymphovenous anastomosis (LVA), identifying functional channels and assessing dermal backflow severity.
Specificity of 55% for diagnosis; primary role is surgical planning.
MR Lymphangiography
Outlines lymphatic vasculature of the limb with detailed anatomic information. Useful for surgical planning but has a sensitivity of 68% for lymphedema diagnosis.
Can help differentiate lymphedema from lipedema and identify the extent of fibrofatty changes.
Ultrasound & CT
Ultrasound evaluates for deep venous thrombosis and venous insufficiency. CT can evaluate for masses, lipodystrophy, and lymphedema with high sensitivity.
Some surgeons advocate for ultrasound to ensure competency of the deep venous system before surgical intervention.
ISL Staging System
Stage 0 — Latent / Subclinical
Impaired lymph transport is present but no clinically obvious swelling. Patients may have abnormal flow on lymphoscintigraphy. This stage can exist for months or years before overt edema develops.
Stage I — Reversible
Early onset with visible accumulation of protein-rich fluid. Swelling subsides with limb elevation. Pitting edema may be present. Tissue is still soft and compliant.
Stage II — Spontaneously Irreversible
Elevation rarely reduces swelling. Pitting is manifest early, but tissue fibrosis develops over time, leading to non-pitting edema. Progressive fibrofatty deposition occurs.
Stage III — Lymphostatic Elephantiasis
Tissue is hard and fibrotic; pitting is absent. Skin changes include thickening, hyperpigmentation, papillomatosis, and warty overgrowths. Significant functional impairment.
Conservative Management
Complete decongestive therapy remains the cornerstone of lymphedema treatment.
Non-Operative Treatment
Conservative management through Complete Decongestive Therapy (CDT) is the foundation of lymphedema care.
Complete Decongestive Therapy (CDT) is the gold standard of conservative lymphedema management. It is a two-phase program: an intensive reduction phase (Phase I) performed by trained therapists, followed by a lifelong maintenance phase (Phase II) managed by the patient. CDT consists of four core components that work synergistically to reduce limb volume and prevent disease progression.
Manual Lymphatic Drainage (MLD)
Specialized, gentle massage techniques that redirect lymphatic fluid from congested areas into functional lymphatic territories. MLD follows specific anatomic pathways and uses light pressure to stimulate lymphatic contractility. Sessions typically last 40–60 minutes and are performed daily during the reduction phase.
Compression Therapy
Phase I: Multi-layered short-stretch bandaging applied after each MLD session. The bandages provide a semi-rigid casing that enhances the muscle pump effect during movement.
Phase II: Custom-fitted compression garments (Class II–III, 30–40+ mmHg) worn daily to maintain volume reductions achieved during Phase I.
Decongestive Exercise
Structured exercise programs performed while wearing compression garments. Movement activates the skeletal muscle pump, which propels lymphatic fluid proximally. Exercises are tailored to the affected limb and may include resistance training, flexibility work, and aerobic activity.
Skin Care & Hygiene
Meticulous skin care is essential to prevent cellulitis and other infections, which are common complications of lymphedema. This includes daily cleansing, moisturization with low-pH emollients, prompt treatment of any skin breaks, and antifungal prophylaxis when indicated.
Adjunctive Therapies
Intermittent Pneumatic Compression (IPC): Sequential pneumatic compression devices can be used as an adjunct to CDT, particularly for home management. These devices apply graduated pressure to the limb, helping to move fluid proximally. They are most effective when used in conjunction with compression garments.
Pharmacotherapy: While no medications have been proven to cure lymphedema, benzopyrones (coumarin) and flavonoids have been studied for their potential to reduce high-protein edema. Diuretics are generally not recommended as they can concentrate proteins in the interstitium and worsen fibrosis.
Physiologic Procedures
Microsurgical techniques aim to restore lymphatic drainage and halt disease progression.
Lymphovenous Bypass (LVA)
Supermicrosurgical anastomosis of lymphatic channels to adjacent venules, bypassing obstructed pathways.
Lymphovenous anastomosis (LVA), also known as lymphaticovenular anastomosis, is a supermicrosurgical procedure that creates direct connections between functional lymphatic channels and adjacent subdermal venules. This bypasses the obstructed lymphatic pathways, allowing excess interstitial fluid to drain directly into the venous system. The procedure is performed under high-powered microscopy (20–40x magnification) using specialized instruments and sutures finer than a human hair (11-0 or 12-0 nylon).
Preoperative mapping with ICG lymphography is essential to identify functional lymphatic channels suitable for anastomosis. The procedure involves small incisions (2–3 cm) at sites where functional lymphatics and suitable venules are co-located. Multiple anastomoses (typically 3–8 per limb) are performed to maximize drainage capacity. The anastomosis configurations include end-to-end, end-to-side, and side-to-end techniques.
Outcomes & Evidence
Published outcomes demonstrate significant volume reduction (mean 30–60% excess volume reduction), decreased frequency of cellulitis episodes, and subjective symptom improvement. The procedure is minimally invasive, can be performed under local anesthesia, and has very low morbidity. Many patients are able to reduce or discontinue compression garment use following successful LVA. Long-term patency rates are favorable, with studies showing sustained benefit at 5+ years.
Procedure Details
Local or general
20–40x (supermicroscope)
11-0 or 12-0 nylon
0.3–0.8 mm
3–8 per limb
ISL Stage I–II, linear ICG pattern
Advantages
- •Minimally invasive, small incisions
- •Can be performed under local anesthesia
- •Very low morbidity and complication rate
- •Physiologic restoration of drainage
- •May reduce need for compression garments
Prophylactic Lymphovenous Bypass
Immediate lymphovenous bypass at the time of axillary lymph node dissection to prevent lymphedema development.
Breast cancer-related lymphedema impacts 30% to 47% of women who undergo axillary lymph node dissection (ALND). Given the irreversible and progressive nature of lymphedema, recent focus has shifted toward primary risk-reduction strategies, including immediate prophylactic lymphovenous bypass (LVB) performed at the time of ALND. This approach aims to prevent lymphedema before it develops, rather than treating it after onset.
The technique, also known as LYMPHA (Lymphatic Microsurgical Preventive Healing Approach), involves performing lymphaticovenous anastomosis (LVA) during the same operative session as ALND. Axillary reverse lymphatic mapping is performed using indocyanine green (ICG) and lymphazurin dye to identify arm lymphatics traversing the axilla. These lymphatics are preserved during dissection and anastomosed to available venous tributaries, maintaining lymphatic drainage from the upper extremity.
The surgical technique involves injecting ICG intradermally into the proximal upper inner arm and hand webspaces. SPY-PHI fluorescence imaging visualizes lymphatic channels. During ALND, the breast surgeon and microsurgeon collaborate to identify and preserve lymphatics with sufficient length for LVA. Anastomoses are performed end-to-end or end-to-side under the microscope at 10x magnification using interrupted 10-0 or 11-0 nylon sutures. At completion, ICG is visualized draining through the recipient veins, confirming patency.
Evidence & Outcomes
A retrospective study of 105 patients demonstrated that lymphedema occurred significantly more often in the ALND-only group compared with the ALND+LVB group (50.0% vs 12.2%; P < 0.001). ALND without LVB was an independent risk factor for lymphedema development (odds ratio 4.82; P = 0.003). Median L-Dex bioimpedance scores were significantly lower in the prophylactic LVB group (1.0 vs 9.9), indicating less subclinical fluid accumulation.
A meta-analysis by Johnson et al. found lymphedema rates were significantly higher in patients who underwent ALND alone versus those who underwent LVB and ALND (14.1% vs 2.1%; P = 0.029). The LYMPHA technique has been shown to be feasible with operative times of 32–95 minutes for the LVA portion, with no surgical complications reported.
Indications for Prophylactic LVB
Patients at high risk for lymphedema undergoing:
• Axillary lymph node dissection (ALND)
• Planned postmastectomy radiation
• Neoadjuvant chemotherapy recipients
• Obesity (BMI > 30)
• Age older than 65 years
Technique Highlights
ICG + Lymphazurin reverse mapping
SPY-PHI fluorescence imaging
End-to-end or end-to-side, 10-0/11-0 nylon
1–4 per axilla
32–95 minutes (LVA portion)
ICG drainage through recipient vein
Lymphedema Risk Reduction
50% → 12%
Lymphedema incidence with prophylactic LVB vs. ALND alone
Postoperative Protocol
- •Custom Class I compression sleeve for 2 weeks
- •Arm elevation < 90° for 2 weeks post-op
- •L-Dex bioimpedance monitoring at follow-up
- •ICG lymphangiography to confirm patency
- •Multidisciplinary surveillance program
Vascularized Lymph Node Transfer
Microvascular transplantation of functional lymph nodes to restore lymphatic drainage in the affected extremity.
Vascularized lymph node transfer (VLNT) involves the microvascular transplantation of lymph nodes along with their arterial and venous blood supply from a donor site to the lymphedema-affected extremity. The transplanted nodes serve as a "lymphatic pump," actively absorbing interstitial fluid and draining it into the venous system through their native lymphaticovenous connections.
Beyond their immediate pumping function, transplanted lymph nodes promote lymphangiogenesis — the growth of new lymphatic vessels — through the release of vascular endothelial growth factor C (VEGF-C) and other lymphangiogenic cytokines. This bridging effect can restore lymphatic continuity across areas of obstruction, providing long-term physiologic benefit.
VLNT is particularly valuable for patients with more advanced disease or when functional lymphatic channels for LVA are not available. It can be combined with other procedures such as simultaneous breast reconstruction (using a deep inferior epigastric perforator flap with inguinal nodes) or performed as a standalone procedure. The recipient site is typically the axilla, groin, wrist, or ankle, depending on the affected extremity.
Outcomes demonstrate significant volume reduction (40–60%), decreased cellulitis episodes, and improved quality of life. Some patients achieve sufficient improvement to discontinue compression therapy, though this is not universal.
Donor Site Options for VLNT
| Donor Site | Vascular Pedicle | Advantages | Considerations |
|---|---|---|---|
| Groin (Superficial Inguinal) | Superficial circumflex iliac vessels | Reliable anatomy, can combine with DIEP flap | Risk of donor limb lymphedema; reverse mapping recommended |
| Supraclavicular | Transverse cervical vessels | Low donor site morbidity, concealed scar | Smaller flap, proximity to thoracic duct |
| Submental | Submental artery (facial artery branch) | Minimal donor morbidity, good node count | Marginal mandibular nerve risk |
| Lateral Thoracic | Lateral thoracic or thoracodorsal vessels | Avoids extremity donor site | Variable anatomy |
| Gastroepiploic (Intra-abdominal) | Right gastroepiploic vessels | No risk of extremity lymphedema, abundant nodes | Requires laparotomy or laparoscopy |
| Jejunal Mesenteric | Jejunal mesenteric vessels | No risk of extremity lymphedema, rich lymphatic tissue | Requires laparotomy, bowel manipulation |
Ablative Procedures
When fibrofatty deposition predominates, debulking procedures offer effective volume reduction.
Liposuction for Lymphedema
Suction-assisted lipectomy removes hypertrophied adipose tissue in chronic, non-pitting lymphedema.
In chronic lymphedema, the persistent inflammatory environment leads to significant hypertrophy of adipose tissue within the affected limb. This excess fat does not respond to elevation, compression, or diuretics — it requires physical removal. Liposuction (suction-assisted lipectomy) has emerged as a highly effective treatment for this fibroadipose component of chronic lymphedema, pioneered by Brorson and colleagues in Sweden.
The procedure involves circumferential power-assisted liposuction performed through small stab incisions. A tourniquet is typically used to minimize blood loss. The technique is performed in a dry fashion (without tumescent solution in some protocols) to maximize fat removal. Importantly, the procedure does not damage remaining lymphatic vessels, as these structures are resilient to the cannula.
The critical postoperative requirement is strict, lifelong, continuous (24/7) use of custom-made compression garments. Without compression, the newly created dead space will rapidly fill with fluid, negating the surgical benefit. Patients must understand and commit to this requirement before surgery. With proper compliance, liposuction can achieve complete reduction of excess volume, returning the limb to a size comparable to the unaffected side.
Outcomes
Studies demonstrate complete reduction of excess volume in the majority of patients, with mean aspirate volumes of 1,000–3,000 mL depending on limb size. The procedure significantly reduces the incidence of cellulitis (by approximately 75%), likely due to removal of the protein-rich adipose substrate that harbors bacteria. Quality of life improvements are substantial and sustained at long-term follow-up.
Indications
Late Stage II and Stage III lymphedema characterized by:
• Non-pitting edema (fibroadipose predominance)
• Failed conservative therapy
• Significant volume excess despite CDT
• Patient committed to lifelong compression
Technique Highlights
Circumferential power-assisted
Used to minimize blood loss
1,000–3,000 mL typical
24/7 lifelong custom garments
Volume Reduction
100%
Complete excess volume reduction achievable with strict compression compliance
Skin Excision Procedures
Radical excisional techniques for severe, end-stage lymphedema with massive tissue changes.
Direct excision procedures involve the surgical removal of affected skin and subcutaneous tissue from the lymphedematous limb. These are reserved for the most severe cases of lymphedema — typically Stage III (elephantiasis) — where massive skin changes, recurrent infections, and functional impairment have not responded to other treatments. While these procedures carry higher morbidity than microsurgical options, they can provide dramatic functional improvement in extreme cases.
The Charles Procedure
Originally described by Sir Richard Henry Havelock Charles in the early 20th century, this procedure involves radical debridement of all soft tissue superficial to the skeletal muscle, followed by skin grafting (often using split-thickness grafts harvested from the excised tissue) directly onto the muscle fascia.
The procedure is indicated for severe elephantiasis with massive skin changes, recurrent cellulitis unresponsive to other treatments, and significant functional impairment. It provides dramatic volume reduction but at the cost of significant scarring and altered limb aesthetics.
Significant scarring, graft loss risk, poor cosmesis, but dramatic functional improvement. Requires careful wound management postoperatively.
Staged Excision (Homans)
The staged excision technique (also known as the Homans, Sistrunk, or Thompson procedure) involves removing ellipses of skin and subcutaneous tissue in multiple operations staged 3 months apart. Thick tissue flaps (1–2 cm) are elevated, underlying soft tissue is excised down to the muscle fascia, and flap edges are closed primarily.
This approach is less radical than the Charles procedure and preserves more native skin, resulting in better cosmetic outcomes. However, it requires multiple surgeries and may not achieve the same degree of volume reduction in the most severe cases.
Better cosmesis than Charles procedure, preserves native skin, but requires multiple staged operations. Closure with permanent suture (e.g., 3-0 nylon).
Treatment Algorithm
An evidence-based framework for selecting the appropriate intervention based on disease stage and tissue composition.
The management of lymphedema follows a stepwise approach, beginning with conservative therapy and escalating to surgical intervention when indicated. The choice of surgical procedure depends on the disease stage, tissue composition (fluid vs. fibroadipose predominance), availability of functional lymphatic channels, and patient factors. Physiologic and ablative procedures are not mutually exclusive and may be combined for optimal results.
Lymphedema Treatment Algorithm
LYMPHA technique — reduces lymphedema risk from 50% to 12%
MLD + Compression + Exercise + Skin Care (minimum 6 months)
Pitting edema, early stages
Physiologic Procedures
Non-pitting, late stages
Ablative Procedures
Surgical Options Comparison
| Procedure | Type | Best Stage | Volume Reduction | Morbidity |
|---|---|---|---|---|
| Prophylactic LVB | Preventive | At time of ALND | N/A (prevention) | Very Low |
| LVA | Physiologic | I – early II | 30–60% | Very Low |
| VLNT | Physiologic | I – III | 40–60% | Low–Moderate |
| Liposuction | Ablative | Late II – III | Up to 100% | Low–Moderate |
| Charles Procedure | Ablative | III (elephantiasis) | Dramatic | High |
| Staged Excision | Ablative | II – III | Moderate–Significant | Moderate |
References & Further Reading
Key literature supporting the content presented in this educational resource.
Greene AK, Goss JA. Diagnosis and Staging of Lymphedema. Semin Plast Surg. 2018;32(1):12-16.
DOI: 10.1055/s-0038-1635117
Brorson H. Liposuction in Lymphedema Treatment. J Reconstr Microsurg. 2016;32(1):56-65.
DOI: 10.1055/s-0035-1549158
Chang DW. Lymphaticovenular Bypass for Lymphedema Management in Breast Cancer Patients. Ann Breast Surg. 2021;5:17.
DOI: 10.21037/abs-20-117
Ciudad P, et al. Vascularized Lymph Node Transfer for Treatment of Lymphedema. Semin Plast Surg. 2018;32(1):28-35.
DOI: 10.1055/s-0038-1632401
Sheckter CC, Johannet P. Fasciocutaneous Debulking of Extremity Lymphedema: The Charles Procedure. Plastic Surgery Key.
International Society of Lymphology. The Diagnosis and Treatment of Peripheral Lymphedema: 2020 Consensus Document. Lymphology. 2020;53(1):3-19.
Garza R, et al. A Comprehensive Overview on the Surgical Management of Secondary Lymphedema of the Upper and Lower Extremities. J Surg Oncol. 2017;115(2):137-151.
DOI: 10.1002/jso.24523
Brorson H, Svensson H. Liposuction Combined With Controlled Compression Therapy Reduces Arm Lymphedema More Effectively Than Controlled Compression Therapy Alone. Plast Reconstr Surg. 1998;102(4):1058-1067.
Koshima I, et al. Supermicrosurgical Lymphaticovenular Anastomosis for the Treatment of Lymphedema in the Upper Extremities. J Reconstr Microsurg. 2000;16(6):437-442.
DOI: 10.1055/s-2000-8516
Cheng MH, et al. Vascularized Groin Lymph Node Flap Transfer for Postmastectomy Upper Limb Lymphedema. Plast Reconstr Surg. 2013;131(6):1286-1298.
DOI: 10.1097/PRS.0b013e31828bd3e5
Deldar R, et al. Prophylactic Lymphovenous Bypass at the Time of Axillary Lymph Node Dissection Decreases Rates of Lymphedema. Ann Surg Open. 2023;4(2):e278.
DOI: 10.1097/AS9.0000000000000278
Lipman K, et al. Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for Lymphedema Prevention after Axillary Lymph Node Dissection. J Clin Med. 2021;11(1):92.
DOI: 10.3390/jcm11010092
Frequently Asked Questions
Answers to the most common questions about lymphedema diagnosis, treatment options, and what to expect.
Lymphedema is a chronic condition caused by impaired lymphatic drainage, leading to swelling — most commonly in the arms or legs. Primary lymphedema results from congenital abnormalities of the lymphatic system, while secondary lymphedema (the most common form in Western countries) develops after damage to the lymphatic system from cancer surgery, radiation therapy, infection, or trauma. Worldwide, the most common cause is filariasis.
Surgical treatment is typically considered when conservative management (Complete Decongestive Therapy) has been optimized but fails to adequately control symptoms. Physiologic procedures like lymphovenous bypass (LVA) are most effective in earlier stages (ISL Stage I–II) when lymphatic channels are still functional. Debulking procedures such as liposuction are considered for later stages with significant fibrofatty deposition. Your surgeon will evaluate your staging, imaging, and response to conservative therapy to determine the best approach.
Lymphovenous anastomosis (LVA) is a supermicrosurgical procedure that creates direct connections between functioning lymphatic channels and small venules, allowing lymphatic fluid to drain into the venous system. The procedure uses vessels as small as 0.3–0.8 mm in diameter and is performed under local or general anesthesia through small incisions. ICG lymphography is used preoperatively to map functional lymphatic channels. Most patients experience measurable volume reduction and improved symptoms.
VLNT involves transplanting healthy lymph nodes along with their blood supply from a donor site (such as the groin, submental area, supraclavicular region, or lateral thoracic area) to the affected limb. The transferred nodes act as a 'lymphatic pump,' absorbing interstitial fluid and bridging gaps in the damaged lymphatic system. This procedure is particularly useful for patients with more advanced disease or those who are not candidates for LVA.
The LYMPHA (Lymphatic Microsurgical Preventive Healing Approach) procedure is performed at the time of lymph node dissection to prevent lymphedema from developing. During the cancer surgery, blue-dyed lymphatic channels are identified and immediately anastomosed to a branch of the axillary or femoral vein. Studies show this can reduce lymphedema incidence from approximately 30–50% down to 4–12%, making it a powerful preventive strategy.
In chronic lymphedema, the persistent protein-rich fluid triggers inflammation that leads to fibrofatty tissue deposition. Once this solid tissue has formed, it does not respond to compression or physiologic surgery alone. Liposuction (suction-assisted lipectomy) can remove this excess adipose tissue, achieving significant volume reduction — often normalizing limb volume. However, lifelong compression garment wear is mandatory after the procedure to maintain results.
Recovery varies by procedure. LVA is minimally invasive with most patients returning to normal activities within 1–2 weeks. VLNT involves a longer recovery of 4–6 weeks due to the flap harvest. Liposuction requires wearing compression garments continuously, with initial recovery of 2–4 weeks. Excisional procedures (Charles, Homans) have the longest recovery, typically 6–8 weeks. All patients continue their compression therapy and CDT program postoperatively.
Many insurance plans do cover lymphedema surgery, particularly when conservative management has been documented and shown to be insufficient. Coverage varies by plan and procedure. Our office can help with prior authorization and provide the necessary documentation, including records of conservative therapy, imaging studies, and clinical measurements. We recommend contacting your insurance provider and our office to discuss coverage specifics.
While there is currently no definitive cure for lymphedema, surgical treatment can significantly improve symptoms, reduce limb volume, decrease infection frequency, and improve quality of life. Physiologic procedures (LVA, VLNT) aim to restore lymphatic drainage, while debulking procedures remove excess tissue. Most patients still require some degree of ongoing conservative management after surgery, though the intensity is often reduced.
To make the most of your consultation, please bring: your medical records related to lymphedema (including any imaging studies like lymphoscintigraphy or ICG lymphography), a list of current medications, documentation of previous treatments (CDT, compression therapy), and any measurements or photos tracking your condition over time. Wearing loose, comfortable clothing will help with the physical examination. Our team will guide you through the evaluation process.
Request a Consultation
Take the first step toward managing your lymphedema. Complete the form below to request a consultation with Dr. Chaiyasate.